Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,353 | 4,091 | 1,808 | 3,488 | 4,799 |
| TOTAL | $6,884 | $4,428 | $2,934 | $4,367 | $5,592 |
| Non-Current Assets | |||||
| PPE Net | 6 | 7 | 8 | 9 | 9 |
| Other Non-Current Assets | 141 | 152 | 14 | 28 | 41 |
| TOTAL | $147 | $159 | $22 | $37 | $50 |
| Total Assets | $7,031 | $4,587 | $2,956 | $4,404 | $5,642 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,236 | 637 | 1,410 | 988 | 307 |
| Accrued Expenses | 935 | 999 | 1,270 | 1,143 | 1,193 |
| Other current liabilities | N/A | 1 | 3 | 18 | 63 |
| TOTAL | $2,216 | $1,680 | $2,697 | $2,177 | $1,604 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 96 | 109 | 0 | 0 | 0 |
| TOTAL | $96 | $109 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,312 | $1,789 | $2,697 | $2,177 | $1,604 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 172 | 17 | 14 | 2 | 2 |
| Retained earnings | -35,670 | -33,420 | -31,533 | -29,529 | -27,392 |
| TOTAL | $4,719 | $2,798 | $259 | $2,227 | $4,038 |
| Total Liabilities And Equity | $7,031 | $4,587 | $2,956 | $4,404 | $5,642 |